184 related articles for article (PubMed ID: 36081499)
1. mRNAsi-related metabolic risk score model identifies poor prognosis, immunoevasive contexture, and low chemotherapy response in colorectal cancer patients through machine learning.
Weng M; Li T; Zhao J; Guo M; Zhao W; Gu W; Sun C; Yue Y; Zhong Z; Nan K; Liao Q; Sun M; Zhou D; Miao C
Front Immunol; 2022; 13():950782. PubMed ID: 36081499
[TBL] [Abstract][Full Text] [Related]
2. Integrative Analysis of Biomarkers Through Machine Learning Identifies Stemness Features in Colorectal Cancer.
Wei R; Quan J; Li S; Liu H; Guan X; Jiang Z; Wang X
Front Cell Dev Biol; 2021; 9():724860. PubMed ID: 34568334
[No Abstract] [Full Text] [Related]
3. Low ferroptosis score predicts chemotherapy responsiveness and immune-activation in colorectal cancer.
Lv Y; Feng QY; Zhang ZY; Zheng P; Zhu DX; Lin Q; Chen SM; Mao YH; Xu YQ; Ji ML; Xu JM; He GD
Cancer Med; 2023 Jan; 12(2):2033-2045. PubMed ID: 35855531
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a circular RNA regulatory stemness-related gene pair signature for predicting prognosis and therapeutic response in colorectal cancer.
Chen Q; Tang P; Huang H; Qiu X
Front Immunol; 2022; 13():934124. PubMed ID: 35958575
[TBL] [Abstract][Full Text] [Related]
5. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
[TBL] [Abstract][Full Text] [Related]
6. Identification of a lncRNA prognostic signature-related to stem cell index and its significance in colorectal cancer.
Wang XC; Liu Y; Long FW; Liu LR; Fan CW
Future Oncol; 2021 Aug; 17(23):3087-3100. PubMed ID: 33910362
[TBL] [Abstract][Full Text] [Related]
7. Integrated Profiling Identifies
Shi J; Bao M; Wang W; Wu X; Li Y; Zhao C; Liu W
Front Immunol; 2021; 12():722807. PubMed ID: 34646265
[TBL] [Abstract][Full Text] [Related]
8. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
Front Immunol; 2022; 13():887048. PubMed ID: 35784334
[TBL] [Abstract][Full Text] [Related]
9. CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer.
Peng QH; Wang CH; Chen HM; Zhang RX; Pan ZZ; Lu ZH; Wang GY; Yue X; Huang W; Liu RY
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33579737
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating podoplanin
Liu X; Cao Y; Lv K; Gu Y; Jin K; He X; Fang H; Fei Y; Shi M; Lin C; Liu H; Li H; He H; Xu J; Li R; Zhang H
Oncoimmunology; 2020 Nov; 9(1):1845038. PubMed ID: 33235820
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
[TBL] [Abstract][Full Text] [Related]
13. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
Xu Q; Xu H; Chen S; Huang W
Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
[No Abstract] [Full Text] [Related]
14. HOXC6: A promising biomarker linked to an immunoevasive microenvironment in colorectal cancer based on TCGA analysis and cohort validation.
Weng M; Lai Y; Ge X; Gu W; Zhang X; Li L; Sun M
Heliyon; 2024 Jan; 10(1):e23500. PubMed ID: 38192826
[No Abstract] [Full Text] [Related]
15. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
[TBL] [Abstract][Full Text] [Related]
16. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
17. Identification of biomarkers for acute leukemia via machine learning-based stemness index.
Zhang Y; Liu D; Li F; Zhao Z; Liu X; Gao D; Zhang Y; Li H
Gene; 2021 Dec; 804():145903. PubMed ID: 34411647
[TBL] [Abstract][Full Text] [Related]
18. Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options.
Liu Z; Xu H; Weng S; Ren Y; Han X
Front Immunol; 2022; 13():828330. PubMed ID: 35154148
[TBL] [Abstract][Full Text] [Related]
19. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
20. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients.
Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
